Abstract
Aim: The role of glycaemia as a coronary artery disease (CAD) risk factor is controversial, and the optimal glucose level is still a matter of debate. For this reason, we assessed the prevalence and severity of angiographic CAD across hyperglycaemia categories and in relation to haemoglobin A1c (HbA1c) levels. Methods: We studied 273 consecutive patients without prior revascularization undergoing coronary angiography for suspected ischaemic pain. CAD severity was assessed using three angiographic scores: the Gensini's score; extent score; and arbitrary index. Patients were grouped, according to 2003 American Diabetes Association criteria, into those with normal fasting glucose (NFG), impaired fasting glucose (IFG) and diabetes mellitus (DM). Results: CAD prevalence was 2.5-fold higher in both the IFG and DM groups compared with the NFG group. Deterioration of glycaemic profile was a multivariate predictor of angiographic CAD severity (extent score: P=0.027; arbitrary index: P=0.007). HbA1c levels were significantly higher among CAD patients (P=0.016) and in those with two or more diseased vessels (P=0.023) compared with the non-CAD group. HbA1c levels remained predictive of CAD prevalence even after adjusting for conventional risk factors, including DM (adjusted OR: 1.853; 95% CI: 1.269-2.704). Conclusion: Non-diabetic hyperglycaemia, assessed either categorically by fasting glucose categories or continuously by HbA1c levels, correlates with the poorest angiographic outcomes.
Translated title of the contribution | Non-diabetic hyperglycaemia correlates with angiographic coronary artery disease prevalence and severity |
---|---|
Original language | French |
Pages (from-to) | 402-408 |
Number of pages | 7 |
Journal | Diabetes and Metabolism |
Volume | 36 |
Issue number | 5 |
DOIs | |
State | Published - Nov 2010 |
Externally published | Yes |
Keywords
- Coronary artery disease
- Haemoglobin A
- Impaired fasting glucose
- Non-diabetic hyperglycaemia
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Endocrinology